Iomed (Acquired)

Noninvasive, site-specific drug delivery technology to deliver compounds to the posterior segments of the eye.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Iomed (Acquired) plus 5849 other startups.

Learn More

Learn More About Iomed (Acquired)

Technology/product details

Competing Startups

More

Companies We Work With